• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

iStent Inject(第二代小梁微通道分流器)与超声乳化白内障吸除术联合应用于开角型青光眼和白内障的手术治疗:1 年结果。

iStent Inject (Second-generation Trabecular Microbypass) Versus Nonpenetrating Deep Sclerectomy in Association With Phacoemulsification for the Surgical Treatment of Open-angle Glaucoma and Cataracts: 1-Year Results.

机构信息

Paletta Guedes Eye Institute.

Federal University of Juiz de Fora, Juiz de Fora, MG, Brazil.

出版信息

J Glaucoma. 2020 Oct;29(10):905-911. doi: 10.1097/IJG.0000000000001576.

DOI:10.1097/IJG.0000000000001576
PMID:32555056
Abstract

PRECIS

Both nonpenetrating deep sclerectomy (NPDS) and iStent inject are safe and effective when combined with phacoemulsification. The NPDS group presented lower final intraocular pressure (IOP); however, more postoperative intervention and longer recovery time was required.

AIM

The aim of this study was to assess the 1-year efficacy and safety of second-generation trabecular microbypass stent implantation (iStent inject) versus NPDS in association with phacoemulsification (Phaco) for the concomitant surgical treatment of open-angle glaucoma and cataracts.

MATERIALS AND METHODS

This was a single-center longitudinal retrospective comparative study of eyes treated with Phaco-NPDS, with adjunctive use of collagen matrix implant and mitomycin C (group 1), or Phaco-iStent inject (group 2). The main outcome measures were success rates [absolute success: proportion of eyes with IOP<18 mm Hg without any glaucoma medication; relative success: proportion of eyes achieving different target IOPs (<18; <15; and <12 mm Hg) with or without medication]; mean reduction (%) in IOP and medication use; number of postoperative reinterventions (goniopuncture, needling, and reoperation); and number of complications.

RESULTS

The mean age (y) was 69.3 in group 1 and 72.7 in group 2. Groups 1 (n=51) and 2 (n=32) achieved absolute success rates of 74.5% and 81.3%, respectively (P=0.333). Concerning relative success rates, no significant difference was found for IOP<18 mm Hg or an IOP<15 mm Hg between the 2 groups. However, significantly more eyes achieved an IOP <12 mm Hg in the Phaco-NPDS group. The mean percentage of IOP reduction from baseline to the end of follow-up was also statistically higher in group 1 (39.9% vs. 24.5%). Both groups achieved similar results in the mean reduction of medications per eye. No significant complications were found in either group, but patients in group 1 required more postoperative intervention than group 2.

CONCLUSIONS

Both techniques are safe and effective for the concomitant surgical treatment of open-angle glaucoma and cataracts and presented comparable relative success rates at different target IOP levels (<18 and <15 mm Hg). A larger proportion of patients in group 1 achieved a target IOP <12 mm Hg; however, more postoperative intervention was required.

摘要

摘要

非穿透性深层巩膜切除术(NPDS)和 iStent inject 联合超声乳化术均安全有效。NPDS 组的最终眼压(IOP)较低;然而,需要更多的术后干预和更长的恢复时间。

目的

本研究旨在评估第二代小梁微旁路支架植入术(iStent inject)与 NPDS 联合超声乳化术(Phaco)同期治疗开角型青光眼合并白内障的 1 年疗效和安全性。

材料与方法

这是一项单中心、纵向回顾性比较研究,纳入接受 Phaco-NPDS 治疗的患者,联合使用胶原基质植入物和丝裂霉素 C(第 1 组)或 Phaco-iStent inject(第 2 组)。主要观察指标为成功率[绝对成功率:IOP<18mmHg 且无需任何降眼压药物的眼数比例;相对成功率:IOP 达到不同目标值(<18mmHg、<15mmHg 和<12mmHg)的眼数比例,无论是否使用药物];IOP 和药物使用的平均降低率(%);术后再干预(前房穿刺、针刺和再次手术)的数量;并发症的数量。

结果

第 1 组(n=51)和第 2 组(n=32)的平均年龄(岁)分别为 69.3 和 72.7。第 1 组和第 2 组的绝对成功率分别为 74.5%和 81.3%(P=0.333)。在相对成功率方面,两组间 IOP<18mmHg 或 IOP<15mmHg 的差异无统计学意义。然而,Phaco-NPDS 组有更多的眼达到 IOP<12mmHg 的目标。从基线到随访结束时,第 1 组的 IOP 平均降低率也显著更高(39.9%比 24.5%)。两组的平均每只眼药物用量减少率相似。两组均未发现明显的并发症,但第 1 组的患者需要更多的术后干预。

结论

两种技术均安全有效,可同期治疗开角型青光眼合并白内障,在不同目标眼压水平(<18mmHg 和<15mmHg)下具有相似的相对成功率。第 1 组中有更大比例的患者达到 IOP<12mmHg 的目标;然而,需要更多的术后干预。

相似文献

1
iStent Inject (Second-generation Trabecular Microbypass) Versus Nonpenetrating Deep Sclerectomy in Association With Phacoemulsification for the Surgical Treatment of Open-angle Glaucoma and Cataracts: 1-Year Results.iStent Inject(第二代小梁微通道分流器)与超声乳化白内障吸除术联合应用于开角型青光眼和白内障的手术治疗:1 年结果。
J Glaucoma. 2020 Oct;29(10):905-911. doi: 10.1097/IJG.0000000000001576.
2
Outcomes of phacoemulsification combined with two iStent inject trabecular microbypass stents with or without endocyclophotocoagulation.超声乳化白内障吸除术联合使用或不联合使用内路环光凝的两种 iStent inject 小梁微旁路引流植入物的效果。
Br J Ophthalmol. 2020 Oct;104(10):1378-1383. doi: 10.1136/bjophthalmol-2019-315434. Epub 2020 Jan 24.
3
Intraocular Pressure After Cataract Surgery Combined With Ab Interno Trabeculectomy Versus Trabecular Micro-bypass Stent: An Intrasubject Same-surgeon Comparison.白内障手术后联合内路小梁切开术与小梁微旁路支架植入术的眼压比较:同一术者的自身对照研究。
J Glaucoma. 2020 Sep;29(9):773-782. doi: 10.1097/IJG.0000000000001547.
4
Use of a Collagen Matrix Implant as an Adjuvant in Combined Surgery Involving Phacoemulsification and Nonpenetrating Deep Sclerectomy.使用胶原基质植入物作为超声乳化白内障吸除术联合非穿透性深层巩膜切除术的辅助手段。
J Glaucoma. 2019 Apr;28(4):363-366. doi: 10.1097/IJG.0000000000001191.
5
Effectiveness of iStent Trabecular Microbypass System Combined with Phacoemulsification versus Phacoemulsification Alone in Patients with Glaucoma and Cataract Depending on the Initial Intraocular Pressure.iStent Trabecular Microbypass 系统联合超声乳化白内障吸除术与单纯超声乳化白内障吸除术治疗青光眼合并白内障的疗效比较:基于初始眼压的影响。
Ophthalmic Res. 2021;64(2):327-336. doi: 10.1159/000511456. Epub 2020 Sep 9.
6
Matched Cohort Study of Cataract Surgery With and Without Trabecular Microbypass Stent Implantation in Primary Angle-Closure Glaucoma.原发性闭角型青光眼白内障手术联合与不联合小梁微旁路支架植入的配对队列研究
Am J Ophthalmol. 2021 Apr;224:310-320. doi: 10.1016/j.ajo.2020.12.032. Epub 2021 Jan 9.
7
Combined non-penetrating deep sclerectomy with phacoemulsification versus non-penetrating deep sclerectomy alone.穿透性深层巩膜切除术联合超声乳化术与单纯穿透性深层巩膜切除术的比较。
Semin Ophthalmol. 2014 May;29(3):146-50. doi: 10.3109/08820538.2013.874466. Epub 2014 Feb 7.
8
Comparison of 1-Year Effectiveness of Trabecular Microbypass Stent implantation (iStent) in Conjunction With Phacoemulsification Among Mild, Moderate, and Severe Primary Open-angle Glaucoma Patients.小梁微旁路支架植入术(iStent)联合超声乳化术治疗轻度、中度和重度原发性开角型青光眼患者 1 年疗效比较。
J Glaucoma. 2020 Jul;29(7):542-549. doi: 10.1097/IJG.0000000000001542.
9
The EX-PRESS glaucoma shunt versus nonpenetrating deep sclerectomy with Esnoper implant in combined surgery for open-angle glaucoma: a prospective randomized study.EX-PRESS 青光眼引流阀与 Esnoper 植入物的非穿透性深层巩膜切除术联合治疗开角型青光眼:一项前瞻性随机研究。
Acta Ophthalmol. 2019 Nov;97(7):e952-e961. doi: 10.1111/aos.14023. Epub 2019 Feb 3.
10
Evaluation of a Trabecular Microbypass Stent With Cataract Extraction in Severe Primary Open-angle Glaucoma.白内障摘除术治疗严重原发性开角型青光眼的小梁微旁路支架评估。
J Glaucoma. 2018 Jan;27(1):71-76. doi: 10.1097/IJG.0000000000000825.

引用本文的文献

1
Minimally invasive bleb surgery versus minimally invasive glaucoma surgery: a 12-month retrospective study.微创滤泡手术与微创青光眼手术:一项为期 12 个月的回顾性研究。
Sci Rep. 2024 Jun 4;14(1):12850. doi: 10.1038/s41598-024-61811-y.
2
The PreserFlo MicroShunt in the Context of Minimally Invasive Glaucoma Surgery: A Narrative Review.《微创青光眼手术中 PreserFlo 微分流管的应用:叙事性综述》。
Int J Environ Res Public Health. 2023 Feb 7;20(4):2904. doi: 10.3390/ijerph20042904.
3
Efficacy and Safety of ab Externo Phaco-Canaloplasty versus First-Generation iStent Bypass Implantation Combined with Phacoemulsification in Patients with Primary Open Angle Glaucoma-Early Results.
外路超声乳化白内障吸除联合房角分离术与第一代 iStent 旁路植入联合白内障超声乳化术治疗原发性开角型青光眼的疗效和安全性:早期结果。
Int J Environ Res Public Health. 2023 Jan 12;20(2):1365. doi: 10.3390/ijerph20021365.
4
Multicenter Effectiveness and Disease Stability Through 3 Years After iStentTrabecular Micro-Bypass with Phacoemulsification in Glaucoma and Ocular Hypertension.青光眼和高眼压症患者行iStent小梁微旁路联合超声乳化白内障吸除术3年后的多中心有效性及疾病稳定性
Clin Ophthalmol. 2022 Sep 1;16:2955-2968. doi: 10.2147/OPTH.S373290. eCollection 2022.
5
Corneal Endothelial Cell Loss in Patients After Minimally Invasive Glaucoma Surgery: Current Perspectives.微创青光眼手术后患者的角膜内皮细胞丢失:当前观点
Clin Ophthalmol. 2022 May 25;16:1589-1600. doi: 10.2147/OPTH.S359305. eCollection 2022.
6
Efficacy and safety of non-penetrating glaucoma surgery with phacoemulsification versus non-penetrating glaucoma surgery: a Meta-analysis.超声乳化非穿透性青光眼手术与非穿透性青光眼手术的疗效及安全性:一项Meta分析
Int J Ophthalmol. 2021 Dec 18;14(12):1970-1978. doi: 10.18240/ijo.2021.12.24. eCollection 2021.
7
Microinvasive Glaucoma Surgery: A Review of Schlemm's Canal-Based Procedures.微侵袭性青光眼手术:基于施莱姆管手术的综述。
Clin Ophthalmol. 2021 Mar 11;15:1109-1118. doi: 10.2147/OPTH.S293702. eCollection 2021.